Author

Mauro Lago‐Docampo

Stanford MedicineORCID 0000-0002-8799-6079Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 1 Research Focus:fine-mapping· 1 Assay:GWAS summary statistics· 1 Organism:human· 1 Approach:statistical model· 1

Frequent Co-Authors

Aarno V. PalotieiD· 1 shared Anniina M. TerviiD· 1 shared Caroline Akemi HeckmaniD· 1 shared Erik AbneriD· 1 shared Hanna Maria OllilaiD· 1 shared Jacqueline M. LaneiD· 1 shared Mark J. DalyiD· 1 shared Markus O RamsteiD· 1 shared

Activity by Year

2023-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperGenetic & Genomic Medicine

Aarno V. PalotieORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

The alpha-2A-adrenergic receptor (ADRA2A) modulates susceptibility to Raynaud's syndrome

Anniina M. Tervi, Markus O Ramste, Erik Abner, Paul P. Cheng, Jacqueline M. Lane, Matthew Maher, Vilma Lammi, Satu J. Strausz, Trieu Nguyen, Mauro Lago‐Docampo, Wenduo Gu, Tõnu Esko, Richa Saxena, Aarno V. Palotie, Samuli Ripatti, , Hanna Maria Ollila

This study identifies ADRA2A as a major risk locus for Raynaud's syndrome through genome-wide association analysis and functional validation in vascular smooth muscle cells.

medRxiv · Oct 4, 2023 · PreprintGenetic & Genomic Medicine